Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|September 26, 2018
A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection ControlV Decraene, H T T Phan, R George, et al.
Microbiology Spectrum|February 24, 2022
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune ProfileJeffrey M Sturek, Tania A Thomas, James D Gorham, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2020
Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coliTimothy J Davies, Nicole Stoesser, Anna E Sheppard, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 16, 2026
The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the EUCAST SubcommitteeØrjan Samuelsen, Carla López-Causapé, Frank Møller Aarestrup, et al.
JCI Insight|June 29, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.
JAMA Network Open|January 15, 2025
Blood Culture Use in Medical and Surgical Intensive Care Units and WardsValeria Fabre, Yea-Jen Hsu, Karen C Carroll, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardizationValeria Fabre, Yea-Jen Hsu, Karen C Carroll, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 19